The assay preserves the local relationship between a responding cell and the immunoglobulin it releases. Capture molecules on the culture surface bind antibodies near the secreting cell, while enzyme-linked or fluorescent detection converts those bound antibodies into a visible signal. This spatial arrangement allows individual antibody-producing cells to appear as separate spots or signals rather than only contributing to a pooled measurement.
Capture molecules retain secreted immunoglobulins at the cell’s location, creating the basis for single-cell readout. Detection reagents then reveal the retained antibodies through an enzyme-generated or fluorescent signal. Because the readout depends on both local capture and signal development, these components determine whether antibody-secreting cells can be identified and quantified as distinct responding units.
Bulk measurements summarize antibody present across a sample, whereas this assay links signal to individual antibody-producing cells. That distinction can reveal how many cells respond and whether responses are antigen-specific, rather than showing only the total immunoglobulin level. Consequently, the method complements pooled measurements when researchers investigate cellular sources of humoral immunity.
A typical workflow places antibody-producing cells on a surface containing capture molecules, allowing secreted immunoglobulins to bind nearby during culture. Detection reagents linked to an enzyme or fluorescent label then reveal the captured material as spots or signals. Researchers can use these individual readouts to quantify responding cells and examine the specificity of the antibody response when the assay includes a relevant antigen.
Following infection or vaccination, the assay can identify and compare antigen-specific B-cell responses. Its cell-level readout helps distinguish the presence of responding cells from the overall amount of antibody in a sample. This makes it useful for examining pathogen-specific humoral defense, comparing immune responses between conditions, and assessing how effectively an exposure stimulates antibody production.
The assay supports studies of protective immunity, memory responses, and antibody production during disease. It can also help evaluate immune therapies by showing changes in antibody-producing cell responses, while antigen-focused measurements connect those responses to a pathogen or target. In infection research, these outcomes provide a cellular perspective on humoral defense that complements broader antibody analyses.